Trademarkia Logo

Australia

AU$
TRIGENESIS
Cancelled: Cancelled at the request of IB

Last updated on 8 Dec 2023

Owner Info

Sarepta Therapeutics, Inc.

215 First Street

Cambridge MA 02142, UNITED STATES OF AMERICA

Serial Number

2138720 filed on 20 Jul 2020

Correspondent

Paul C. Llewellyn ARNOLD & PORTER KAYE SCHOLER LLP

250 West 55th Street,

New York NY 10019-9710,

UNITED STATES OF AMERICA

TRIGENESIS

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disor Read More

Class [016]
Printed materials, namely, brochures, leaflets, reports, and newsletters on the topics of medicine, medical research, scientific research, research an Read More

Class [042]
Medical research; medical and scientific research services all in the field of rare and infectious diseases; medical and scientific research services Read More

Class [044]
Medical information services; providing medical information via a website; provision of health care services, namely, providing information to doctors Read More

Mark Details


Serial Number

2138720

Registered On

20 Jul 2020

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

26 Feb 2020

Mark Type

US

Legal History


Show more

Status DateAction Taken
8th Dec 2023Status change to Voided
13th Mar 2021International Registration in Australia Protected correspondence sent
12th Mar 2021Status change to Registered/Protected
12th Mar 2021IP Right Registration Published
5th Jan 2021Application Accepted correspondence sent
4th Jan 2021IP Right has been Examined
4th Jan 2021IP Right Acceptance Published
4th Jan 2021Status change to Accepted
27th Nov 2020Awaiting examination
27th Nov 2020Examination expedited